SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000920465-14-000124
Filing Date
2014-11-18
Accepted
2014-11-18 16:54:27
Documents
6
Period of Report
2014-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K q32014earningsrelease8-k.htm 8-K 24422
2 EXHIBIT a991q32014pressrelease.htm EX-99.1 99026
3 EXHIBIT a992asnposterfinal.htm EX-99.2 11537
4 EXHIBIT a993asnpressrelease.htm EX-99.3 45628
5 a992asnposterfinal001.jpg GRAPHIC 5010599
6 ljpcpressrelease_image1.jpg GRAPHIC 21134
  Complete submission text file 0000920465-14-000124.txt   7114647
Mailing Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36282 | Film No.: 141232503
SIC: 2836 Biological Products, (No Diagnostic Substances)